Latest News

Antidepressant plus addiction medication are elements of new weight-loss drug

A new prescription weight-loss medication that combines a popular antidepressant with a medication for addiction will be reviewed by the Federal Drug Administration (FDA) for potential approval. The new prescription medication is a combination of two FDA-approved drugs, bupropion, an antidepressant and naltrexone, which reduces the desire for drugs and alcohol. Both have been found to increase weight-loss in independent research trials and the partnering of the two in one capsule is believed to create a synergistic effect.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Baicalin suppresses iron accumulation after substantia nigra injury

  • Factors predicting functional recovery of upper limb after peripheral nerve injuries

  • Collaborative care intervention improves depression among teens

  • Sleep apnea treatment is effective for older people

  • Young children's sipping/tasting of alcohol reflects parental modeling

  • Prenatal alcohol exposure is associated with later excess weight/obesity during adolescence

  • Alcoholics have an abnormal CD8 T cell response to the influenza virus

  • New estrogen-based compound suppresses binge-like eating behavior in female mice

  • Protecting brains of very preterm infants

  • Fear, safety and the role of sleep in human PTDS

  •